Marshall Wace North America’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$283K Buy
+12,705
New +$327K ﹤0.01% 1261
2021
Q2
Sell
-14,529
Closed -$328K 1430
2021
Q1
$328K Sell
14,529
-53,618
-79% -$1.31M ﹤0.01% 1292
2020
Q4
$1.61M Sell
68,147
-79,506
-54% -$1.61M 0.01% 813
2020
Q3
$2.73M Buy
+147,653
New +$2.82M 0.02% 508
2018
Q2
Sell
-16,376
Closed -$328K 1371
2018
Q1
$328K Buy
+16,376
New +$313K ﹤0.01% 1245
2017
Q4
Sell
-17,598
Closed -$405K 1356
2017
Q3
$405K Sell
17,598
-115,423
-87% -$2.33M ﹤0.01% 1106
2017
Q2
$2.66M Buy
133,021
+72,114
+118% +$1.29M 0.02% 669
2017
Q1
$1.03M Buy
+60,907
New +$1.08M 0.01% 695

Other funds holding AORT

Marshall Wace North America's AORT Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Artivion (AORT) in Q3 2021: 12,705 shares worth $283K. The stake represents ﹤0.01% of the portfolio and ranks #1261 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in AORT as recently as Q1 2021.

Marshall Wace North America first reported a position in AORT in Q1 2017 and has held it in 8 quarters since. The position peaked at $2.73M in Q3 2020. 135 funds tracked by Wall St. Rank hold AORT as of Q3 2021.

  • Marshall Wace North America held 12,705 shares of Artivion worth $283K as of Q3 2021.
  • Artivion was a new Marshall Wace North America position in Q3 2021.
  • Artivion made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1261 holding.
  • Marshall Wace North America first reported a position in Artivion in Q1 2017 and has held it in 8 quarters since.
  • Marshall Wace North America's Artivion position peaked at $2.73M in Q3 2020.
  • 135 funds tracked by Wall St. Rank held Artivion as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.